Physicians' Academy for Cardiovascular Education

Mode of action of potassium binders

10' education - Mar. 1, 2022 - Joost Beusekamp, MD, PhD – Groningen, The Netherlands

Video navigation menu

  • How to treat hyperkalemia in the acute phase? 00:29
  • Therapeutic options for long-term hyperkalemia management 03:18
  • Differences between therapeutic options 09:23


Show transcript

Educational information

This lecture by Joost Beusekamp is part of a series titled "3 Things a cardiologist needs to know about potassium binders".

This program has been designed to provide cardiologists insights in the role of potassium binding as RAASi enabling therapy in the management of patients with cardiorenal disease and /or heart failure. This series consists of three presentations.


Joost Beusekamp, MD, PhD – Groningen, The Netherlands


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.


Funding for this educational program was provided by an unrestricted educational grant received from Vifor.

Watch the other videos of this educational series on potassium binders View the slides of this presentation

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: